Skip to main content
Top
Published in: Malaria Journal 1/2010

Open Access 01-12-2010 | Research

Testing the sensitivity and specificity of the fluorescence microscope (Cyscope®) for malaria diagnosis

Authors: Saad El-Din H Hassan, Somia I Okoued, Mahmoud A Mudathir, Elfatih M Malik

Published in: Malaria Journal | Issue 1/2010

Login to get access

Abstract

Background

Early diagnosis and treatment of malaria are necessary components in the control of malaria. The gold standard light microscopy technique has high sensitivity, but is a relatively time-consuming procedure especially during epidemics and in areas of high endemicity. This study attempted to test the sensitivity and specificity of a new diagnostic tool - the Cyscope® fluorescence microscope, which is based on the use of Plasmodium nucleic acid-specific fluorescent dyes to facilitate detection of the parasites even in low parasitaemia conditions due to the contrast with the background.

Methods

In this study, 293 febrile patients above the age of 18 years attending the malaria treatment centre in Sinnar State (Sudan) were interviewed using a structured questionnaire. Finger-prick blood samples were also collected from the participants to be tested for malaria using the hospital's microscope, the reference laboratory microscope, as well as the Cyscope® microscope. The results of the investigations were then used to calculate the sensitivity, specificity, and positive and negative predictive values of the Cyscope® microscope in reference to gold standard light microscopy.

Results

The sensitivity was found to be 98.2% (95% CI: 90.6%-100%); specificity = 98.3% (95% CI: 95.7% - 99.5%); positive predictive value = 93.3% (95% CI: 83.8% - 98.2%); and negative predictive value = 99.6% (95% CI: 97.6% - 100%).

Conclusions

In conclusion, the Cyscope® microscope was found to be sensitive, specific and provide rapid, reliable results in a matter of less than 10 minutes. The Cyscope® microscope should be considered as a viable, cheaper and time-saving option for malaria diagnosis, especially in areas where Plasmodium falciparum is the predominant parasite.
Literature
1.
go back to reference WHO: Global strategic plan: 2005-2015. 2005, Geneva: Roll Back Malaria Partnership Secretariat WHO: Global strategic plan: 2005-2015. 2005, Geneva: Roll Back Malaria Partnership Secretariat
2.
go back to reference Bell D, WCBJ: Ensuring quality and access for malaria diagnosis: how can it be achieved?. Nat Rev Microbiol. 2006, 4: S7-20. 10.1038/nrmicro1525.CrossRefPubMed Bell D, WCBJ: Ensuring quality and access for malaria diagnosis: how can it be achieved?. Nat Rev Microbiol. 2006, 4: S7-20. 10.1038/nrmicro1525.CrossRefPubMed
3.
go back to reference National Malaria Programme: Sudan Strategic Plan for RBM, 2001 - 2010. 2001 National Malaria Programme: Sudan Strategic Plan for RBM, 2001 - 2010. 2001
4.
go back to reference Talisuna AO, OPEACMDU: Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg. 2007, 77: 170-180.PubMed Talisuna AO, OPEACMDU: Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg. 2007, 77: 170-180.PubMed
5.
go back to reference Reyburn H, MRDCCIMEMOSKSJKAORGBWC: Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004, 329: 1212-10.1136/bmj.38251.658229.55.PubMedCentralCrossRefPubMed Reyburn H, MRDCCIMEMOSKSJKAORGBWC: Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004, 329: 1212-10.1136/bmj.38251.658229.55.PubMedCentralCrossRefPubMed
7.
go back to reference WHO: Malaria diagnostics, New Perspectives. 2000 WHO: Malaria diagnostics, New Perspectives. 2000
8.
go back to reference Haditsch M: Quality and reliability of current malaria diagnostic methods. Trav. 2004, 2: 149-160. Haditsch M: Quality and reliability of current malaria diagnostic methods. Trav. 2004, 2: 149-160.
9.
go back to reference Guy R, LPPPCI: The use of fluorescence enhancement to improve the microscopic diagnosis of falciparum malaria. Malar J. 2007, 6: 89-10.1186/1475-2875-6-89.PubMedCentralCrossRefPubMed Guy R, LPPPCI: The use of fluorescence enhancement to improve the microscopic diagnosis of falciparum malaria. Malar J. 2007, 6: 89-10.1186/1475-2875-6-89.PubMedCentralCrossRefPubMed
11.
go back to reference Banoo S, BDBPHAMDPFSPSNWCLRORPMCJMPNCOPPRRA: Evaluation of diagnostic tests for infectious diseases: General principles. Nat Rev Microbiol. 2006, 4: S21-S31. 10.1038/nrmicro1570.CrossRefPubMed Banoo S, BDBPHAMDPFSPSNWCLRORPMCJMPNCOPPRRA: Evaluation of diagnostic tests for infectious diseases: General principles. Nat Rev Microbiol. 2006, 4: S21-S31. 10.1038/nrmicro1570.CrossRefPubMed
12.
go back to reference WHO: Towards Quality Testing of Malaria Rapid Diagnostic Tests: Evidence and Methods. TDR. 2006 WHO: Towards Quality Testing of Malaria Rapid Diagnostic Tests: Evidence and Methods. TDR. 2006
Metadata
Title
Testing the sensitivity and specificity of the fluorescence microscope (Cyscope®) for malaria diagnosis
Authors
Saad El-Din H Hassan
Somia I Okoued
Mahmoud A Mudathir
Elfatih M Malik
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2010
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-88

Other articles of this Issue 1/2010

Malaria Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.